[1]万琦文,郭荣增,张亦鹏,等.纳美芬与尼莫地平治疗儿童急性外伤性蛛网膜下腔出血后脑血管痉挛疗效比较[J].新乡医学院学报,2023,40(11):1065-1068.[doi:10.7683/xxyxyxb.2023.11.011]
　WAN Qiwen,GUO Rongzeng,ZHANG Yipeng,et al.Comparison of the clinical efficacy of nalmefene and nimodipine in the treatment of cerebral vasospasm of children with acute traumatic subarachnoid hemorrhage[J].Journal of Xinxiang Medical University,2023,40(11):1065-1068.[doi:10.7683/xxyxyxb.2023.11.011]
点击复制

纳美芬与尼莫地平治疗儿童急性外伤性蛛网膜下腔出血后脑血管痉挛疗效比较
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年11
页码:
1065-1068
栏目:
临床研究
出版日期:
2023-11-05

文章信息/Info

Title:
Comparison of the clinical efficacy of nalmefene and nimodipine in the treatment of cerebral vasospasm of children with acute traumatic subarachnoid hemorrhage
作者:
万琦文; 郭荣增; 张亦鹏; 刘炳学
（无锡市儿童医院神经外科，江苏　无锡　214000）
Author(s):
WAN Qiwen; GUO Rongzeng; ZHANG Yipeng; LIU Bingxue
（Department of Neurosurgery,Wuxi Children′s Hospital,Wuxi 214000,Jiangsu Province,China）
关键词:
儿童; 急性外伤性蛛网膜下腔出血; 脑血管痉挛; 纳美芬; 尼莫地平
Keywords:
child; acute traumatic subarachnoid hemorrhage; cerebral vasospasm; nalmefene; nimodipine
分类号:
R651.1
DOI:
10.7683/xxyxyxb.2023.11.011
文献标志码:
A
摘要:
目的　比较纳美芬与尼莫地平治疗儿童急性外伤性蛛网膜下腔出血后脑血管痉挛的临床效果。
方法　选择2018年2月至2022年2月无锡市儿童医院收治的65例儿童急性外伤性蛛网膜下腔出血患儿为研究对象，按随机数字表法将患儿分为纳美芬组（n=33）和尼莫地平组（n=32）。所有患儿急诊入院后给予脱水、止血、保持呼吸道通畅、抗感染、维持水电解质和酸碱平衡及全身营养支持治疗等常规对症治疗。纳美芬组患儿在上述常规对症治疗的基础上给予盐酸纳美芬注射液0.05~0.10 mg，静脉推注，每日2次，连续治疗10 d。尼莫地平组患儿在上述常规对症治疗的基础上给予尼莫地平注射液15 μg·kg-1·h-1，持续静脉泵注24 h，连续治疗10 d。比较2组患儿在治疗前及治疗第3、7、10 天格拉斯哥昏迷量表（GCS）评分、Lindegaard指数和颅内压。
结果　纳美芬组和尼莫地平组患儿GCS评分随着治疗时间延长均呈逐渐上升趋势（F=213.219、59.526，P<0.001）。治疗前，2组患儿GCS评分比较差异无统计学意义（P>0.05）；治疗第3、7、10 天，纳美芬组患儿的GCS评分显著高于尼莫地平组（P<0.05）。纳美芬组和尼莫地平组患儿Lindegaard指数随着治疗时间延长呈逐渐下降趋势（F=802.972、914.436，P<0.001）。治疗前及治疗第3、10天，纳美芬组与尼莫地平组患儿的Lindegaard指数比较差异无统计学意义（P>0.05）；治疗第7天，尼莫地平组患儿的Lindegaard指数显著低于纳美芬组（P<0.05）。纳美芬组和尼莫地平组患儿颅内压值随着治疗时间延长呈逐渐下降趋势（F=2 570.042、828.963，P<0.001）；治疗前，2组患儿颅内压值比较差异无统计学意义（P>0.05）；治疗第3、7、10 天，纳美芬组患儿颅内压值显著低于尼莫地平组（P<0.05）。
结论　纳美芬和尼莫地平均能显著预防和减少急性外伤性蛛网膜下腔出血患儿脑血管痉挛的发生，盐酸纳美芬的促醒和降低颅内压作用强于尼莫地平。
Abstract:
Objective　To compare the clinical effects of nimodipine and nalmefene in the treatment of cerebral vasospasm of children with acute traumatic subarachnoid hemorrhage.
Methods　A total of 65 children with acute traumatic subarachnoid hemorrhage admitted to Wuxi Children′s Hospital from February 2018 to February 2022 were selected as the study subjects.The children were divided into the nemetifen group(n=33) and nimodipine group(n=32) using a random number table method.After emergency admission,all children received routine symptomatic treatment such as dehydration,hemostasis,maintaining respiratory patency,anti-infection,maintaining water and electricity balance and acid-base balance,and systemic nutritional support.On the basis of the above conventional symptomatic treatment,the children in the namefene group were given intravenous injection of 0.05-0.10 mg namefene hydrochloride injection,twice a day for 10 consecutive days;the children in the nimodipine group were given nimodipine injection,continuously intravenous infused with 15 μg·kg-1·h-1 for 24 hours,continuous treatment for 10 days.The Glasgow coma scale (GCS) score,Lindegaard index,and intracranial pressure were compared between the two groups before treatment and on the 3rd,7th and 10th day of treatment.
Results　The GCS scores of children showed a gradually increasing trend with prolonged treatment time in the nalmafene group and nimodipine group (F=213.219,59.526;P<0.001).There was no statistically significant difference in GCS scores of children between the two groups before treatment (P>0.05).On the 3rd,7th and 10th day of treatment,the GCS scores of children in the nalmafene group were significantly higher than those in the nimodipine group (P<0.05).The Lindegaard index of children showed a gradually decreasing trend with prolonged treatment time in the nalmafene group and nimodipine group (F=802.972,914.436;P<0.001).There was no statistically significant difference in Lindegaard index of children between the nalmafene group and the nimodipine group before treatment and on the 3rd and 10th day of treatment (P>0.05).On the 7th day of treatment,the Lindegaard index of children in the nimodipine group was significantly lower than that in the nalmafene group (P<0.05).The intracranial pressure value of children showed a gradually decreasing trend with prolonged treatment time in the nalmafene group and nimodipine group (F=2 570.042,828.963;P<0.001).There was no statistically significant difference in intracranial pressure value of children between the two groups before treatment (P>0.05).On the 3rd,7th and 10th day of treatment,the intracranial pressure value of children in the nalmafene group was significantly lower than that in the nimodipine group (P<0.05).
Conclusion　Nalmafene and nimodipine can significantly prevent and reduce the occurrence of cerebral vasospasm in children with acute traumatic subarachnoid hemorrhage.The effects of nalmafene for promoting wake-up and reducing intracranial pressure are stronger than those of nimodipine.

参考文献/References:

［1］　王艮卫,吴楠,牛光明,等.法舒地尔联合尼莫地平治疗蛛网膜下腔出血后脑血管痉挛的临床研究［J］.中国临床药理学杂志,2016,32(11):963-965.
WANG G W,WU N,NIU G M,et al.Clinical trial of fasudil combined with nimodipine in the treatment of patients with cerebral vasospasm after subarachnoid hemorrhage［J］.Chin J Clin Pharmacol,2016,32(11):963-965.
［2］　MCCARTHY M T,KOSOFSKY B E.Clinical features and biomarkers of concussion and mild traumatic brain injury in pediatric patients［J］.Ann N Y Acad Sci,2015,1345:89-98.
［3］　苏联春,周国灿,苏朝勇.盐酸纳美芬治疗急性重症颅脑损伤的临床疗效观察［J］.中外医疗,2010,29(35):5-6.
SU L C,ZHOU G C,SU C Y.Therapeutic effects of nalmefene in severe craniocerebral injury patients［J］.China Foreign Med Treat,2010,29(35):5-6.
［4］　李高伟.尼莫地平在创伤性蛛网膜下腔出血治疗中的应用价值［J］.深圳中西医结合杂志,2015,25(22):105-106.
LI G W.Application value of nimodipine in the treatment of traumatic subarachnoid hemorrhage［J］. Shenzhen J Integr Tradit Chin West Med,2015,25(22):105-106.
［5］　杨树源,张建宁.神经外科学［M］.2版.北京:人民卫生出版社,2015:872-879.
YANG S Y,ZHANG J N.Neurosurgery［M］.2nd ed.Beijing:People′s Medical Publishing House,2015:872-879.
［6］　REBEIZ T,SABIROV T,WANCHOO S,et al.Angiographic treatment of asymptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage for the prevention of delayed cerebral ischemia［J］.World Neurosurg,2022,166:e135-e139.
［7］　SALVADORI E,POGGESI A,DONNINI I,et al.Efficacy and safety of the association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease.The CONIVaD trial［J］.Drugs Aging,2021,38(6):481-491.
［8］　CARLSON A P,HNGGI D,MACDONALD R L,et al.Nimodipine reappraised:an old drug with a future［J］.Curr Neuropharmacol,2020,18(1):65-82.
［9］　陈光旭,廖志玉.尼莫地平治疗外伤性蛛网膜下腔出血后脑血管痉挛的疗效分析［J］.北方药学,2015,12(11):168.
CHEN G X,LIAO Z Y.Therapeutic effect of nimodipine on cerebral vasospasm after traumatic subarachnoid hemorrhage［J］.J N Pharm,2015,12(11):168.
［10］　LIU J,SUN C,WANG Y,et al.Efficacy of nimodipine in the treatment of subarachnoid hemorrhage:a meta-analysis［J］.Arq Neuropsiquiatr,2022,80(7):663-670.
［11］　牛明庆.改良大骨瓣开颅减压术治疗重度颅脑损伤患者的临床效果分析［J］.世界最新医学信息文摘,2017,17(56):23-24.
NIU M Q.Clinical effect analysis of modified large bone flap decompressive craniectomy treating severe craniocerebral injury patients［J］.World Latest Med Inf,2017,17(56):23-24.
［12］　贺波.纳美芬对急性重症颅脑损伤患者血清β-EP和NSE水平的影响［J］.西南国防医药,2016,26(9):991-993.
HE B.Effects of nalmefene on levels of β-EP and NSE of patients with acute severe traumatic brain injury［J］.Med J Natl Defending Forces Southwest China,2016,26(9):991-993.
［13］　查海锋,路楷.盐酸纳美芬联合电针刺激治疗急性脑损伤患者的临床效果及其对血清D-二聚体、内源性阿片肽水平的影响［J］.实用心脑肺血管病杂志,2019,27(9):91-94.
ZHA H F,LU K.Clinical effect of nalmefene combined with electroacupuncture stimulation on acute brain injury and the impact on serum levels of D-dimer and endogenous opioid peptide［J］.Pract J Card Cereb Pneumal Vasc Dis,2019,27(9):91-94.

相似文献/References:

[1]元帅,史世峰,孙丽君,等.儿童行为问题研究现状[J].新乡医学院学报,,():000.
[2]于贵珍,郑素华,张文林,等.1120例儿童及青少年行为问题的调查研究[J].新乡医学院学报,1990,7(03):201.
[3]田明德.儿童转换型癔症25例报告[J].新乡医学院学报,1990,7(03):221.
[4]张华荣,卢振民,冯连铭,等.儿童急性中耳炎鼓膜穿孔的探讨[J].新乡医学院学报,1993,10(01):033.
[5]石太新,赵卫星,王礼周,等.小儿再生障碍性贫血骨髓细胞核仁形成区蛋白定量研究[J].新乡医学院学报,1995,12(02):147.
[6]席鸿钧,陈莹,李汉臣,等.经胃壁潜道食管胃粘膜腔内吻合治疗小儿食管狭窄[J].新乡医学院学报,1995,12(03):230.
[7]薛克修,陈金兰,支凌翔,等.儿童前臂缺血性挛缩的治疗[J].新乡医学院学报,1996,13(04):384.
[8]殷琪.儿童特发性高钙尿症12例[J].新乡医学院学报,1996,13(01):091.
[9]郑素华,付桂玲,张文林,等.行为异常儿童社交能力分析[J].新乡医学院学报,1997,14(04):363.
[10]贾东萱,石太新,贾汝贤,等.小儿恶性肿瘤及白血病226例回顾性分析[J].新乡医学院学报,1997,14(04):405.

更新日期/Last Update: 2023-11-05